Prognostic Value of sST2 in Heart Failure

被引：19

作者：

Sciatti, Edoardo ^{[1
]}

Merlo, Anna ^{[2
]}

Scangiuzzi, Claudio ^{[2
]}

Limonta, Raul ^{[2
]}

Gori, Mauro ^{[1
]}

D'Elia, Emilia ^{[1
]}

Aimo, Alberto ^{[3
,4
]}

Vergaro, Giuseppe ^{[3
,4
]}

Emdin, Michele ^{[3
,4
]}

Senni, Michele ^{[1
,2
]}

机构：

[1] ASST Papa Giovanni XXIII, Cardiol Unit, I-24127 Bergamo, Italy

[2] Univ Milano Bicocca, Sch Med & Surg, I-20126 Milan, Italy

[3] Scuola Super Sant Anna, Hlth Sci Interdisciplinary Ctr, I-56127 Pisa, Italy

[4] Fdn Toscana G Monasterio, I-56124 Pisa, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 12期

关键词：

ST2; heart failure; biomarker; natriuretic peptide; prognosis; SENSITIVITY TROPONIN-T; SOLUBLE ST2; NATRIURETIC PEPTIDE; MYOCARDIAL FIBROSIS; RISK STRATIFICATION; BIOMARKERS; MORTALITY; RECEPTOR; PREDICTION; MANAGEMENT;

D O I：

10.3390/jcm12123970

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recent years, there has been growing interest in the risk stratification for heart failure, and the use of multiple biomarkers to identify different pathophysiological processes associated with this condition. One such biomarker is soluble suppression of tumorigenicity-2 (sST2), which has shown some potential for integration into clinical practice. sST2 is produced by both cardiac fibroblasts and cardiomyocytes in response to myocardial stress. Other sources of sST2 are endothelial cells of the aorta and coronary arteries and immune cells such as T cells. Indeed, ST2 is also associated with inflammatory and immune processes. We aimed at reviewing the prognostic value of sST2 in both chronic and acute heart failure. In this setting, we also provide a flowchart about its potential use in clinical practice.

引用

页数：10

共 50 条

[11] Clinical and Prognostic Significance of sST2 in Heart Failure JACC Review Topic of the Week
Aimo, Alberto
Januzzi, James L., Jr.
Bayes-Genis, Antoni
Vergaro, Giuseppe
Sciarrone, Paolo
Passino, Claudio
Emdin, Michele
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (17) : 2193 - 2203
[12] Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure
Zhang, Rongcheng
Zhang, Yuhui
An, Tao
Guo, Xiao
Yin, Shijie
Wang, Yunhong
Januzzi, James L.
Cappola, Thomas P.
Zhang, Jian
BIOMARKERS IN MEDICINE, 2015, 9 (05) : 433 - 441
[13] The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure
Binas, David
Daniel, Hanna
Richter, Anette
Ruppert, Volker
Schlueter, Klaus-Dieter
Schieffer, Bernhard
Pankuweit, Sabine
OPEN HEART, 2018, 5 (01):
[14] Prognostic value of sST2 and Galectin-3 considering different etiologies in non-ischemic heart failure
Binas, D.
Daniel, H.
Richter, A.
Ruppert, V.
Schieffer, B.
Pankuweit, S.
EUROPEAN HEART JOURNAL, 2016, 37 : 918 - 918
[15] sST2 and Heart Failure-Clinical Utility and Prognosis
Dudek, Magdalena
Kaluzna-Oleksy, Marta
Migaj, Jacek
Sawczak, Filip
Krysztofiak, Helena
Lesiak, Maciej
Straburzynska-Migaj, Ewa
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
[16] The value of soluble suppression of tumorigenesis-2 (sST2) in the maintenance of hemodialysis patients with heart failure
Zhou, X.
Yi, F.
Peng, L.
Jiang, J.
Lan, L.
HIPPOKRATIA, 2022, 26 (01) : 19 - 24
[17] sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment
Barutaut, M.
Fournier, P.
Peacock, W. F.
Dambrin, C.
Caubere, C.
Servoz, C.
Koukoui, F.
Galinier, M.
Smih, F.
Rouet, P.
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 241 - 242
[18] Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
Huang, Anan
Qi, Xin
Hou, Wenguang
Qi, Yanfang
Zhao, Na
Liu, Keqaing
ACTA CARDIOLOGICA, 2018, 73 (01) : 41 - 48
[19] The biological variability of sST2, a novel serum biomarker for heart failure
Wu, A.
Snider, J.
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S299 - S299
[20] Serum Cat S, TSP-1, IL-11, BNP and sST2 Diagnostic and Prognostic Value in Chronic Heart Failure
Xiang, Yang
Zhang, Zhixin
Xie, Cui
Wang, Lin
Wu, You
Zhan, Yu
Chen, Dan
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2022, 28 (04) : 55 - 59

← 1 2 3 4 5 →